Metabolism, Inborn Errors D008661

Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Metabolism, Inborn Errors

Description

Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.   MeSH

Hierarchy View

Subtype Terms (15)

Amino Acid Metabolism, Inborn Errors
6 drugs (4 approved, 2 experimental)

Amino Acid Transport Disorders, Inborn
 

Amyloidosis, Familial
10 drugs (8 approved, 2 experimental)

Brain Diseases, Metabolic, Inborn
1 experimental drug

Carbohydrate Metabolism, Inborn Errors
2 drugs (1 approved, 1 experimental)

Cytochrome-c Oxidase Deficiency
 

Hyperbilirubinemia, Hereditary
 

Lipid Metabolism, Inborn Errors
6 drugs (2 approved, 4 experimental)

Lysosomal Storage Diseases
19 drugs (8 approved, 11 experimental)

Metal Metabolism, Inborn Errors
1 approved drug

Peroxisomal Disorders
14 drugs (10 approved, 4 experimental)

Progeria
7 drugs (4 approved, 3 experimental)

Purine-Pyrimidine Metabolism, Inborn Errors
 

Renal Tubular Transport, Inborn Errors
 

Steroid Metabolism, Inborn Errors
1 approved drug


Phase 3 Indicated Drugs (3)


Organization Involved with Phase 1 Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.